相关实验视频
Updated: Jun 16, 2025

10:02
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
32.1K
[在慢性非传染性脑膜炎中植入的静脉内皮质类固醇]
L J Kessler1, M Albrecht1, T Naujokaitis1
1Universitätsaugenklinik Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland.
Die Ophthalmologie
|August 15, 2024
概括
室内皮质类固醇植入物有效治疗非传染性脑膜炎和脑膜斑点,减少复发和管理急性活动. 虽然通常是安全的,但像白内障这样的潜在副作用需要与患者进行仔细讨论,特别是年轻人或老年人.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
背景情况:
- 尿道炎导致明显的视力丧失,在工业化国家影响10-15%的病例.
- 目前的治疗方法包括局部/全身类固醇和免疫调节剂.
- 静脉内皮质类固醇为慢性或耐火性脑膜炎提供了替代方案,特别是在脑膜炎性黄斑胀时.
研究的目的:
- 审查目前用于非传染性脑膜炎的静脉内皮质类固醇植入物.
- 根据现有文献,讨论适应症,有效性和副作用概况.
- 评估随机对照研究和子组分析的结果.
主要方法:
- 对6项随机对照性研究的综述,这些研究涉及氨醇乙化物 (FAc) 和甲 (DEX) 植入物.
- 包括来自多中心随机研究 (315名患者) 的子组分析.
主要成果:
- 静脉内皮质类固醇在治疗乌维性黄斑胀方面表现出有效性.
- 长效植入物可以减少复发频率,并延长缓解间隔.
- 短效植入物适用于治疗急性脑膜炎发作.
结论:
- 静脉内皮质类固醇提供了可行的治疗乌维性黄斑胀与可管理的副作用.
- 长效植入物对长期疾病控制有好处.
- 关于潜在的不良影响 (如白内障) 的患者咨询至关重要,特别是对于年轻或发病的患者.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
103
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
103
Open Angle Glaucoma: Treatment
413
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
413

